APLN and pulmonary arterial hypertension: Finally, agents that activate apelin expression or act as downstream effectors of apelin signaling have demonstrated beneficial effects in PAH animal models (Kim et al., 2013; Spiekerkoetter et al., 2013; Bertero et al., 2014; Nickel et al., 2015).